secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2023-10-31T23:59:59+00:00
Accession:  0001104659-23-113014
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies First Wave BioPharma of non-compliance with shareholder approval rule for July offering
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 26, 2023 for failing to obtain shareholder approval under Listing Rule 5635(d) for a July best-efforts offering.
- Offering included 610,000 shares, 2,675,000 pre-funded warrants, and 6,570,000 common warrants at $0.64 per share.
- Staff determined the offering was not a public offering because one investor purchased a predominant portion.
- Company has 45 days to submit a compliance plan; if accepted, Nasdaq may grant up to 180 calendar days to cure.
- Common stock continues to trade on Nasdaq under symbol FWBI while the compliance process is ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923113014/0001104659-23-113014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923113014/tm2329533d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-113014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer